Refining the role of preoperative C‐reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma
- 25 April 2013
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 123 (11) , 2690-2699
Abstract
Objectives/Hypothesis: Elevated inflammatory biomarkers such as C‐reactive protein (CRP) and the recently identified neutrophil/lymphocyte ratio (NLR) were demonstrated to be associated with prognosis in human cancers. The aim of our present study is to analyze the relationship of preoperative levels of CRP and NLR with clinicopathological factors and prognosis in oral squamous cell carcinoma (OSCC) patients.Study Design: Retrospective study.Methods: This study was performed on 226 OSCC patients between July 2007 and April 2012. Their serum CRP levels and NLR were measured preoperatively.Results: CRP level ≥ 5.0 mg/L was significantly associated with NLR ≥ 2.44 (linear regression, P < .001). Elevated CRP and NLR were significantly associated with pathological tumor status (P < .001), pathologic nodal metastasis (P < .001), tumor depth (≥10 mm vs. P < .001), disease‐free survival (P < .001), and overall survival (P = .001). The influence of CRP level and NLR on disease‐free survival (hazard ratio [HR] = 2.259, 95% confidence interval [CI] = 1.170‐4.361) and overall survival (HR = 2.176, 95% CI = 1.116‐4.245]) still existed after adjusting for tumor status, lymph node metastasis, and tumor cell differentiation.Conclusions: The present study demonstrates that elevated CRP is an independent prognostic factor in OSCC. Elevated NLR in the high CRP group identifies patients at high risks of recurrence and shorter survival. Incorporating NLR into CRP level therefore has significant potential as a biomarker for risk stratification in OSCC.Level of Evidence: 4. Laryngoscope, 123:2690–2699, 2013Keywords
This publication has 34 references indexed in Scilit:
- Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)Clinical Cancer Research, 2012
- Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical studyInvestigational New Drugs, 2012
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical CystectomyUrology, 2012
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer PatientsAnnals of Surgical Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- C-reactive protein levels: a prognostic marker for patients with head and neck cancer?Head & Neck Oncology, 2010
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric CancerOncology, 2007
- Inflammation and cancerNature, 2002